FDA staff flags concerns about Pfizer's quit-smoking drug study

(Reuters) - Pfizer Inc's trial data on Chantix, a drug to help people quit smoking, failed to impress U.S. Food and Drug Administration scientists, in a blow to the company's attempts to have a serious warning removed from the drug's label.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news